Nov. 11, 2011, 3:59 PM
Helix BioPharma (HBP -3.6%) falls after saying the clinical hold on its new drug application for its cervical lesion drug trial has been removed by the FDA, however the company still lacks the funding to start the trial.| Nov. 11, 2011, 3:59 PM
Currently, there's no company description for HBPC.
Industry: Medical Appliances & Equipment
Other News & PR